www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Make me your Homepage
left corner left corner
China Daily Website

Alibaba and PE firm set to take control of info provider in HK

Updated: 2014-01-25 08:06
By Lin Jing ( China Daily)

E-commerce giant Alibaba Group Holding Ltd and private equity firm Yunfeng Capital bought a majority stake in Hong Kong-listed information provider CITIC 21CN Co Ltd for HK$1.324 billion ($171 million), according to a statement filed with the Hong Kong Stock Exchange late Thursday.

Alibaba and Yunfeng - a firm set up by Alibaba chairman Jack Ma - will hold 38.1 percent and 16.2 percent stakes in the company, respectively, becoming the largest shareholder of CITIC 21CN with a combined 54.3 percent.Alibaba and PE firm set to take control of info provider in HK

Alibaba said in an e-mailed statement that the deal is the foundation for a strategic partnership to jointly drive development of a pharmaceutical information platform, Bloomberg News reported.

CITIC 21CN, a unit of the Citic Group, which mainly provides telecommunications and information value-added services, said that it plans to further develop and expand its domestic drug data platform as well as a data standard for medical and healthcare products, based on Alibaba's expertise in cloud computing, data processing and e-business platforms.

It added that the deal will help to bring in financial flexibility, extensive experience and Alibaba's wide business network to the company.

CITIC 21CN's stock price soared after the transaction. The company's shares closed at HK$3.92 on Thursday, up from HK$0.83 on Jan 15, the last day they had traded.

A total of 4.4 billion shares will be issued to Alibaba and Yunfeng at HK$0.3.

After the transaction, the current five executive directors of CITIC 21CN will leave the company and be replaced by five new managers to be appointed by Alibaba.

Alibaba already has a mature pharmaceutical business operating in Tmall, its vertical e-commerce platform, with 81 major drug companies present in the platform.

Eliza Liu, an economist at CCB International Securities in Hong Kong, said that the transaction is positive for the drug-data industry, a sector in which companies not only sell drugs online to consumers, but also collect personal data and medical history from consumers using technology such as big data.

The HK$1.324 billion investment will be used to fund future expansion and M&A opportunities, CITIC 21CN added.

Liu said that the next step for CITIC 21CN will likely be to acquire a health insurance company.

"It's a typical scenario in developed countries. A group owns a drug-data platform business and also runs a health insurance company. In this way, they can sell health plans to targeted consumers," she said.

Alibaba was said to be seeking a listing in Hong Kong last year, but is thought to have abandoned those plans because Hong Kong listing rules would not allow it to issue dual-class shares, which give top managers more voting power than regular shareholders.

Industry insiders said that Alibaba could use CITIC 21CN as a shell company for a backdoor listing in Hong Kong.

David Webb, a stock analyst in Hong Kong said that Alibaba would probably not get listed using this method.

"The total valuation of Alibaba is about HK$1 trillion. There's no company in Hong Kong that's big enough for Alibaba to conduct a backdoor listing," Webb said.

Ma launched Yunfeng in 2010. The firm mainly focuses on industries such as technology, media and telecom, consumer products and healthcare.

 
8.03K
 
...
主站蜘蛛池模板: 久久99精品久久久久久青青91 | 北岛玲亚洲一区在线观看 | 国产视频在线免费观看 | 久久精品国产亚洲网站 | 日本韩国欧美在线 | 激情性爽三级成人 | 久久综合婷婷香五月 | japanesetubesexfree | 亚洲欧美日韩一级特黄在线 | 亚洲线精品一区二区三区 | 一级生性活免费视频 | 亚洲欧美午夜 | 中文字幕亚洲视频 | 成人韩免费网站 | 免费小视频在线观看 | 欧美黑人巨大最猛性xxxxx | 尹人成人 | 久久久久久久久久久视频国内精品视频 | 美女又黄又免费视频 | 久久久久久毛片免费播放 | 日韩理论在线 | 成人a毛片免费全部播放 | 手机看片在线精品观看 | 久久久精品视频免费观看 | 国产精品久久久久激情影院 | 在线视频久久 | 成人国产免费 | 男女午夜视频在线观看 | 男同黄网站 | 欧美日本一区 | 久久精品国产亚洲网址 | 国产呦系列 | 亚洲成 人a影院青久在线观看 | 88av视频在线 | 欧美成人777| 99这里只有精品视频 | 高h原耽肉汁动漫视频 | 亚洲二三区 | 国产精品毛片 | 久久精品一区二区三区四区 | 久久精品亚洲一级毛片 |